Public signalCompany raiseAuto-indexed · Unverified
BioGene Therapeutics Inc. raised $4.5M
BioGene Therapeutics Inc.· AUSTIN, US· Biotechnology· Filed Jul 23, 2026
BioGene Therapeutics Inc. reported raising capital. Based in AUSTIN, TEXAS, US. First sale reported 2025-04-01. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$4.6M
Confidence90%
Raised
$4.6M
Investors
6
Incorporated
2024
Jurisdiction
TEXAS
On the record
- Location
- AUSTIN, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $4.6M
- Target amount
- $4.6M
- Filing date
- Jul 23, 2026
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- TEXAS
- Year incorporated
- 2024
- Industry group
- Biotechnology
- Number of investors
- 6
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $4.6M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 4,550,000 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jul 23, 2026. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$1M – $10MCompany Raise
Are you associated with BioGene Therapeutics Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record